Acquiring Company
ChronoScale
Acquired Company
Ekso Bionics®
Description
On September 30, 2026, ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. This transaction marks a significant step for ChronoScale as it refocuses its business operations. The separation will enable both companies to pursue their strategic goals more effectively. Following this transaction, Jason C. Jones has been terminated from his position as COO of Ekso.
Fundz sees it the moment ChronoScale makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ekso Bionics®?
Ekso Bionics® was acquired by ChronoScale. The deal was reported on October 2, 2026. ChronoScale is an accelerated compute platform purpose-built to support demanding artificial intelligence workloads. ChronoScale is publicly traded (CHRN) and operates in Software.
When did ChronoScale acquire Ekso Bionics®?
ChronoScale's acquisition of Ekso Bionics® was reported on October 2, 2026. On September 30, 2026, ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. This transaction marks a significant step for ChronoScale as it refocuses its business operations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ekso Bionics® do?
® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. It is publicly traded (CHRN), operating in Manufacturing, and is based in San Rafael.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.